Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift

NCT01444846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Temporary Auditory Threshold Shift

Interventions

DRUG: SPI-1005 Low dose
DRUG: SPI-1005 Middle dose
DRUG: SPI-1005 High dose
DRUG: Placebo

Sponsor

Sound Pharmaceuticals, Incorporated

Collaborators

[object Object]